How many insider declarations has Wirk Shaheen filed?

Wirk Shaheen has filed 6 public insider declarations with SEC (Form 4).

What is Wirk Shaheen's role?

Wirk Shaheen's reported role is not specified by the regulator across the filings.

Which companies does Wirk Shaheen report trades for?

Wirk Shaheen reports trades for 2 companies, including Tvardi Therapeutics, Inc..

← Executives ★ Sign in to follow

WS

Wirk Shaheen

OFFICER

·SEC (Form 4)

Tvardi Therapeutics, Inc.Movano Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-44.7%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Discover the detailed record of transactions filed by Wirk Shaheen. Officer active across 2 companies, notably Tvardi Therapeutics, Inc.. In total, 6 filings have been published. Activity tracked since 9 May 2025. The latest transaction was disclosed on 13 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Wirk Shaheen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Tvardi Therapeutics, Inc. (US)Movano Inc. (US)

申报6 总计

◇

Wirk Shaheen

Director高管2026年3月13日Movano Inc.

US$12,50019SEC ↗

10,000 股@ US$1.25100.0% 占其流量Common StockSEC:0001193125-26-111336:0

◆

Wirk Shaheen

Director高管2025年10月3日Movano Inc.

0SEC ↗

20,685 股0Common StockSEC:0001193125-25-232768:0

◆

Wirk Shaheen

Director高管2025年7月3日Movano Inc.

11SEC ↗

18,657 股0Common StockSEC:0000950170-25-093920:0

◆

Wirk Shaheen

Director高管2025年5月9日Movano Inc.

11SEC ↗

29,070 股0Common StockSEC:0000950170-25-070430:0

◆

Wirk Shaheen

Director高管2025年4月15日Tvardi Therapeutics, Inc.

11SEC ↗

176,030 股Common StockSEC:0001415889-25-011857:0

◆

Wirk Shaheen

Director高管2025年4月15日Tvardi Therapeutics, Inc.

11SEC ↗

4,191 股Common StockSEC:0001415889-25-010980:0

6 条申报中的 6 条

InsidersTradesSigma

← Executives ★ Sign in to follow

WS

Wirk Shaheen

OFFICER

·SEC (Form 4)

Tvardi Therapeutics, Inc.Movano Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-44.7%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Discover the detailed record of transactions filed by Wirk Shaheen. Officer active across 2 companies, notably Tvardi Therapeutics, Inc.. In total, 6 filings have been published. Activity tracked since 9 May 2025. The latest transaction was disclosed on 13 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.